B Buccal DNA methylation-derived EpiScores capture biological signatures associated with neonatal morbidity burden in very preterm infants, and reflected immune, inflammatory, metabolic, and growth-related pathways.
Abstract
Background: Infants <30 weeks gestational age (very preterm (VPT)), are at risk of experiencing multiple serious neonatal morbidities. These morbidities impart serious biological stress, which may be reflected in dysregulated protein expression even after the morbidities have resolved. Recent studies suggest that DNA methylation-based predictors of circulating proteins may reflect the molecular effects of neonatal adversity. The objective of this study is to examine associations between DNA methylation-derived EpiScores, which are externally trained methylation signatures that proxy circulating protein levels, and neonatal morbidity burden in children born VPT. Buccal DNA methylation was obtained at NICU discharge in 537 infants from the NOVI cohort. A total of 111 EpiScores were calculated and tested for association with multimorbidity (0-1 vs. [≥] 2 morbidities) using adjusted linear regression models. Cross-tissue analyses in an external paired blood-buccal dataset (n=21) were used to identify EpiScores with moderate-to-strong correlations across tissues. Results: Eighteen EpiScores were nominally associated with multimorbidity (p < 0.05), with Melanoma-derived growth regulatory protein (MIA) with FDR < 0.05 (beta = 0.0023, p = 0.0004). In cross-tissue analyses, 35 EpiScores yielded r > 0.50 (p<0.05), 11 of which showed nominal associations with multimorbidity, including MIA. Overall, the morbidity-associated EpiScores reflected immune, inflammatory, metabolic, and growth-related pathways. Conclusions: Buccal DNA methylation-derived EpiScores capture biological signatures associated with neonatal morbidity burden in very preterm infants.
DNA methylation is associated with individual differences in birthweight in a high-risk clinical population of MC twins, independent of shared genetic, familial, maternal, and obstetric factors.
M. Sulaiman, L. Franken, J. A. Spekman et al.· medRxiv· 0 citations
Preliminary evidence of DNA methylation signatures linked to potential candidate genes and biological pathways that may be relevant to ADS are provided, supporting the need for validation in larger independent cohorts and functional experimental studies.
C. Thirumoorthy, S. S. Nair, M. Deepa et al.· Neurochemistry International· 0 citations
Preterm birth is strongly linked to systemic inflammation and encephalopathy of prematurity, which underlies subsequent cognitive impairment. T-cell immunity contributes to brain-immune crosstalk across the life course but its role in the pathogenesis of encephalopathy of prematurity is unknown. Protein epigenetic scor...
R. Smikle-Bernard, M. B. Cabez, K. Vaher et al.· medRxiv· 0 citations
Most MPSs are better characterised as research tools at an early stage of development rather than clinical tools, and are highlighted as research tools at an early stage of development rather than clinical tools.
I. Schuurmans, S. Defina, A. P. C. Hermans et al.· The Lancet Child & Adolescen...· 0 citations
The findings suggests that the association between epigenetic aging and neurodevelopment among children born preterm is context dependent and can vary based on the presence of preterm risk factors.
R. Christensen, Chaini Konwar, Beryl C. Zhuang et al.· JAMA Network Open· 0 citations
Prenatal serum PFAS concentrations were associated with alterations in maternal DNA methylation, which in turn were associated with infant birth size, which in turn was associated with infant birth size.
You-Ran Tan, Anne L. Dunlop, Todd M. Everson et al.· Environmental Science and Te...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.